Oncotelic Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Oncotelic Therapeutics, Inc. (OTLC) reported Increase (Decrease) in Accounts Receivable of -$49.27 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- Oncotelic Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$49.27K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$49.27K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$49.27K 10-Q · filed 2026-05-14 |